Skip to main content

Table 3 Prediction results of 12 variants of SCN5A obtained from SUNDS by three online prediction programs (MutationTaster, PROVEAN/SIFT, Human Splicing Finder)

From: Association between SCN5A and sudden unexplained nocturnal death syndrome in Thai decedents: a case–control study

Exon

Variant

Position

Web-based program

MutationTaster

PROVEAN/SIFT

Human Splicing Finder

2

rs6599230

c.87A>G

g.21452A>G

p.Ala29=

Polymorphism

Neutral/tolerated

No significant splicing motif alteration detected.

This mutation has probably no impact on splicing.

12

rs1805124

c.1674A>G

g.50744A>G

p.His558Arg

Polymorphism

Neutral/tolerated

No significant splicing motif alteration detected.

This mutation has probably no impact on splicing.

17

rs7430407

c.3183A>G

g.73697A>G

p.Glu1061==

Polymorphism

Neutral/tolerated

- New acceptor site*

- New ESS site**

- ESE site broken***

28

rs1805126

c.5457 T>C

g.103758 T>C

p.Asp1819=

Polymorphism

Neutral/tolerated

No significant splicing motif alteration detected.

This mutation has probably no impact on splicing.

28

rs376826051

c.5712G>A

g.104013G>A

p.Ser1903=

Disease causing

- Protein features (might be) affected

- Splice site changes

Neutral/tolerated

- New acceptor site*

- New ESS site**

- ESE site broken***

3′UTR

rs7429945

c.*123A>G

g.104475A>G

Polymorphism

NA

NA

3′UTR

rs41310757

c.*753C>T

g.105105C>T

Polymorphism

NA

NA

3′UTR

rs4073797

c.*962T>A

g.105314 T>A

Polymorphism

NA

NA

3′UTR

rs4073796

c.*963C>T

g.105315C>T

Polymorphism

NA

NA

3′UTR

rs11414422

c.*1453_

*1454insA

g.105805_

105806insA

Polymorphism

NA

NA

3′UTR

rs41315485

c.*1537T>C

g.105889 T>C

Polymorphism

NA

NA

3′UTR

rs45592631

c.*2145_

*2146

insGAGA

AGAGAG

TAGGAA

AAAGGA

GGG

g.106497_106,498

insGAGA

AGAGAG

TAGGAA

AAAGGA

GGG

Polymorphism

NA

NA

  1. NA not available
  2. *Activation of an exonic cryptic acceptor site, with presence of one or more cryptic branch point(s)
  3. **Creation of an exonic splicing silencer site (ESS site)
  4. ***Alteration of an exonic splicing enhancer site (ESE site)